These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19971022)

  • 21. Treatment of 5-fluorouracil-induced stomatitis by allopurinol mouthwashes.
    Elzawawy A
    Oncology; 1991; 48(4):282-4. PubMed ID: 1891169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of 1-alkylcarbamoyl-5-fluorouracils in plasma and ascites fluid after oral administration in mice.
    Iigo M; Hoshi A; Kuretani K
    Cancer Chemother Pharmacol; 1980; 4(3):189-93. PubMed ID: 7397942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical consequences of 5-fluorouracil gastrointestinal toxicity in rats; effect of high-dose uridine.
    Kralovanszky J; Prajda N; Kerpel-Fronius S; Bagrij T; Kiss E; Peters GJ
    Cancer Chemother Pharmacol; 1993; 32(3):243-8. PubMed ID: 8500230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of continuous intravenous 5-fluorouracil therapy in 27 patients with neoplasms of the digestive tract].
    Pilone A; Delprete S; Pierangeli S; Frosini G; Pezzoli M
    G Ital Chemioter; 1984; 31(3):249-52. PubMed ID: 6085574
    [No Abstract]   [Full Text] [Related]  

  • 25. Dose escalating clinical study of high dose infusional 5-fluorouracil and leukovorin (AIO regimen) plus alternate weekly administration of oxaliplatin and irinotecan in patients with advanced tumors of the gastrointestinal tract.
    Gkioulbasanis I; Souglakos J; Vardakis N; Kotsakis A; Saridaki Z; Kentepozidis N; Polyzos A; Giassas S; Ignatiadis M; Bozionelou V; Christophylakis C; Georgoulias V
    J BUON; 2007; 12(2):197-202. PubMed ID: 17600872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2'-deoxyuridine.
    Houghton JA; Houghton PJ; Wooten RS
    Cancer Res; 1979 Jul; 39(7 Pt 1):2406-13. PubMed ID: 156065
    [No Abstract]   [Full Text] [Related]  

  • 27. Infusional 5-fluorouracil in the treatment of gastrointestinal cancers: The Royal Marsden Hospital experience.
    Ross PJ; Webb A; Cunningham D; Prendiville J; Norman AR; Oates J
    J Infus Chemother; 1996; 6(3):141-4. PubMed ID: 9229326
    [No Abstract]   [Full Text] [Related]  

  • 28. [5-Fluorouracil(5-FU) in the treatment of adenocarcinomas of the digestive tract (apropos of 13 cases)].
    Vinhafs JC; Ferreira AJ
    Hospital (Rio J); 1967 Feb; 71(2):453-74. PubMed ID: 5302398
    [No Abstract]   [Full Text] [Related]  

  • 29. Continuous 5-fluorouracil infusion causing acute gastric mucosal lesions.
    Suda K; Seki T; Kano Y; Sasagawa M
    Endoscopy; 1993 Aug; 25(6):426-7. PubMed ID: 8404711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elemental diet moderates 5-fluorouracil-induced gastrointestinal mucositis through mucus barrier alteration.
    Kawashima R; Kawakami F; Maekawa T; Yamamoto H; Koizumi W; Ichikawa T
    Cancer Chemother Pharmacol; 2015 Aug; 76(2):269-77. PubMed ID: 26048344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Baker LH; Vaitkevicius VK; Gehan E
    Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of treatment with 5FU in tumors of the gastrointestinal tract].
    Kuten A
    Harefuah; 1976 Sep; 91(5-6):134-6. PubMed ID: 799611
    [No Abstract]   [Full Text] [Related]  

  • 33. [Palliative treatment of digestive tract tumors with 5-fluorouracil alone or combined with radiotherapy (apropos of 55 cases)].
    Gary-Bobo J; Villaret B
    J Radiol Electrol Med Nucl; 1968 Oct; 49(10):763-7. PubMed ID: 4177102
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel chemotherapeutic agents for gastrointestinal cancers.
    Royce ME; Pazdur R
    Curr Opin Oncol; 1999 Jul; 11(4):299-304. PubMed ID: 10416883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitomycin-C alone and in combination with infused 5-fluorouracil to the treatment of disseminated gastrointestinal carcinomas.
    Buroker TR; Kim PN; Baker LH; Ratanatharathron V; Wojtaszak B; Vaitkevicius VK
    Med Pediatr Oncol; 1978; 4(1):35-42. PubMed ID: 342890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized comparison of melphalan and 5-fluorouracil in the treatment of advanced gastrointestinal cancer.
    Bullen BR; Giles GR; Malhotra A; Bird GG; Hall R; Bunch GA; Brown GJ
    Cancer Treat Rep; 1976 Sep; 60(9):1267-71. PubMed ID: 797448
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in mice.
    Letari O; Booth C; Bonazzi A; Garofalo P; Makovec F; Rovati LC; Caselli G
    Cancer Chemother Pharmacol; 2010 Oct; 66(5):819-27. PubMed ID: 20041326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas.
    Sun W; Metz JM; Gallagher M; O'Dwyer PJ; Giantonio B; Whittington R; Haller DG
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):621-7. PubMed ID: 20495918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicities and therapeutic effect of 5-fluorouracil controlled release implant on tumor-bearing rats.
    He YC; Chen JW; Cao J; Pan DY; Qiao JG
    World J Gastroenterol; 2003 Aug; 9(8):1795-8. PubMed ID: 12918123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of morbidity from simultaneous 5-fluorouracil therapy and radiation therapy in advanced gastrointestinal tumors. Report of results].
    Higi M; Arndt D; Schmidt C; Schmitt G
    Strahlentherapie; 1983 Apr; 159(4):208-10. PubMed ID: 6857732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.